SG10201602076QA - Glycosylated polypeptide and pharmaceutical composition containing same - Google Patents
Glycosylated polypeptide and pharmaceutical composition containing sameInfo
- Publication number
- SG10201602076QA SG10201602076QA SG10201602076QA SG10201602076QA SG10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA SG 10201602076Q A SG10201602076Q A SG 10201602076QA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing same
- glycosylated polypeptide
- glycosylated
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011218793 | 2011-10-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201602076QA true SG10201602076QA (en) | 2016-04-28 |
Family
ID=47995870
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201602076QA SG10201602076QA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
| SG11201401071YA SG11201401071YA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401071YA SG11201401071YA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10358470B2 (en) |
| EP (1) | EP2762489B1 (en) |
| JP (1) | JP6153470B2 (en) |
| KR (1) | KR101979045B1 (en) |
| CN (2) | CN109134642A (en) |
| AU (1) | AU2012317325B2 (en) |
| BR (1) | BR112014007766B1 (en) |
| CA (1) | CA2850469C (en) |
| DK (1) | DK2762489T3 (en) |
| IN (1) | IN2014CN02982A (en) |
| MY (1) | MY168902A (en) |
| PH (1) | PH12014500694B1 (en) |
| RU (1) | RU2636456C2 (en) |
| SG (2) | SG10201602076QA (en) |
| TW (1) | TWI633115B (en) |
| WO (1) | WO2013047846A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109134642A (en) | 2011-10-01 | 2019-01-04 | 株式会社糖锁工学研究所 | The polypeptide of addition sugar chain and medical composition containing the polypeptide |
| WO2014157107A1 (en) * | 2013-03-29 | 2014-10-02 | 株式会社糖鎖工学研究所 | Polypeptide having sialylated sugar chains attached thereto |
| CN114685645B (en) * | 2020-12-30 | 2025-03-21 | 深圳翰宇药业股份有限公司 | A synthetic method of semaglutide |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237019A3 (en) * | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
| US6399336B1 (en) | 1997-01-16 | 2002-06-04 | Neose Technologies, Inc. | Practical in vitro sialylation of recombinant glycoproteins |
| DE19717864C2 (en) | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Human recombinant interferon beta, process for its preparation and its use |
| CN100335503C (en) * | 1998-04-28 | 2007-09-05 | 应用研究系统Ars股份公司 | Polyol-ifn-beta conjugates |
| EA004789B9 (en) | 1998-10-16 | 2017-05-31 | Байоджен, Инк. | Polymer conjugates of interferon beta-1a and their uses |
| WO2000023472A2 (en) * | 1998-10-16 | 2000-04-27 | Biogen, Inc. | Interferon-beta fusion proteins and uses |
| US6514729B1 (en) | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
| JP2003520579A (en) * | 1999-12-08 | 2003-07-08 | アムジェン インコーポレイテッド | Interferon-like molecules and uses thereof |
| US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
| SK2772003A3 (en) | 2000-09-08 | 2003-10-07 | Gryphon Therapeutics Inc | Synthetic erythropoiesis stimulating proteins |
| WO2002074806A2 (en) | 2001-02-27 | 2002-09-26 | Maxygen Aps | New interferon beta-like molecules |
| CA2441095A1 (en) | 2001-03-15 | 2002-09-26 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Modified interferon beta with reduced immunogenicity |
| ES2411007T3 (en) * | 2001-10-10 | 2013-07-04 | Novo Nordisk A/S | Remodeling and glycoconjugation of peptides |
| US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| WO2003054006A2 (en) | 2001-12-11 | 2003-07-03 | Aventis Pasteur | Mutated hiv tat |
| IL163577A0 (en) * | 2002-03-12 | 2005-12-18 | Maxygen Aps | Interferon beta-like molecules for treatment of stroke |
| US7943763B2 (en) | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| AU2003254641A1 (en) | 2002-08-28 | 2004-03-19 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
| GEP20094699B (en) * | 2002-09-27 | 2009-06-10 | Biogen Idec Inc | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING ß-INTERFERON |
| WO2004031352A2 (en) | 2002-10-01 | 2004-04-15 | Xencor, Inc. | Interferon variants with improved properties |
| US20060166929A1 (en) | 2002-12-26 | 2006-07-27 | Yasuhiro Kajihara | Sugar-chain asparagine derivatives and processes for the preparation thereof |
| WO2005019260A1 (en) | 2003-08-25 | 2005-03-03 | Toray Industries, Inc. | INTERFERON-β COMPOSITE |
| EP1734988A4 (en) | 2004-03-01 | 2009-08-05 | Enzon Pharmaceuticals Inc | Interferon-beta polymer conjugates |
| WO2006020580A2 (en) | 2004-08-09 | 2006-02-23 | Alios Biopharma Inc. | Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same |
| RU2392963C2 (en) * | 2004-08-09 | 2010-06-27 | Элиоз Байофарма, Инк. | Synthetic versions of hyperglycolised protease-resistive polypeptide, oral compositions and methods of using such versions |
| KR100781666B1 (en) | 2004-11-02 | 2007-12-03 | 신영기 | Human Interferon-beta Variants |
| CN101282990B (en) * | 2005-08-26 | 2013-04-03 | 阿雷斯贸易股份有限公司 | Method for preparing glycosylated interferon-beta |
| US20080003202A1 (en) * | 2006-03-28 | 2008-01-03 | Thierry Guyon | Modified interferon-beta (IFN-beta) polypeptides |
| US20080096819A1 (en) | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| WO2008155900A1 (en) * | 2007-06-19 | 2008-12-24 | Otsuka Chemical Co., Ltd. | Glp-1 peptide having sugar chain attached thereto |
| US8809258B2 (en) | 2007-07-31 | 2014-08-19 | Glytech, Inc. | Method for producing peptide |
| JP2009242372A (en) | 2008-03-11 | 2009-10-22 | Yokohama City Univ | Erythropoietin derivative having uniform sugar chain structure |
| BRPI0914889A2 (en) | 2008-06-17 | 2015-11-24 | Otsuka Chemical Co Ltd | oligosaccharide chain added glp-1 peptide |
| EP2331701B1 (en) * | 2008-08-08 | 2013-03-20 | Vib Vzw | Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| DK2330114T3 (en) * | 2008-08-19 | 2017-11-20 | Glytech Inc | METHOD OF GYCOPROTEIN PREPARATION AND SCREENING PROCEDURE |
| WO2012051615A1 (en) | 2010-10-15 | 2012-04-19 | Transgenrx, Inc. | Novel vectors for production of glycosylated interferon |
| RU2586524C2 (en) | 2011-03-10 | 2016-06-10 | Глитек, Инк. | Process for preparation of glycopeptide having sialylated sugar chain, and method for producing sialyl glycoasparagine |
| EP2727930B1 (en) | 2011-06-29 | 2019-12-25 | Kyowa Kirin Co., Ltd. | Method for purifying antithrombin |
| CN109134642A (en) | 2011-10-01 | 2019-01-04 | 株式会社糖锁工学研究所 | The polypeptide of addition sugar chain and medical composition containing the polypeptide |
-
2012
- 2012-09-28 CN CN201811042210.1A patent/CN109134642A/en active Pending
- 2012-09-28 PH PH1/2014/500694A patent/PH12014500694B1/en unknown
- 2012-09-28 CA CA2850469A patent/CA2850469C/en active Active
- 2012-09-28 RU RU2014116550A patent/RU2636456C2/en active
- 2012-09-28 WO PCT/JP2012/075262 patent/WO2013047846A1/en not_active Ceased
- 2012-09-28 SG SG10201602076QA patent/SG10201602076QA/en unknown
- 2012-09-28 EP EP12836998.0A patent/EP2762489B1/en active Active
- 2012-09-28 US US14/347,222 patent/US10358470B2/en active Active
- 2012-09-28 DK DK12836998.0T patent/DK2762489T3/en active
- 2012-09-28 IN IN2982CHN2014 patent/IN2014CN02982A/en unknown
- 2012-09-28 SG SG11201401071YA patent/SG11201401071YA/en unknown
- 2012-09-28 CN CN201280058952.8A patent/CN104080803B/en not_active Expired - Fee Related
- 2012-09-28 BR BR112014007766-5A patent/BR112014007766B1/en not_active IP Right Cessation
- 2012-09-28 AU AU2012317325A patent/AU2012317325B2/en not_active Ceased
- 2012-09-28 JP JP2013536471A patent/JP6153470B2/en not_active Expired - Fee Related
- 2012-09-28 KR KR1020147010631A patent/KR101979045B1/en not_active Expired - Fee Related
- 2012-09-28 MY MYPI2014000925A patent/MY168902A/en unknown
- 2012-10-01 TW TW101136177A patent/TWI633115B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014007766B1 (en) | 2022-05-10 |
| MY168902A (en) | 2018-12-04 |
| CN104080803A (en) | 2014-10-01 |
| EP2762489B1 (en) | 2018-03-28 |
| RU2636456C2 (en) | 2017-11-23 |
| CA2850469C (en) | 2020-07-07 |
| DK2762489T3 (en) | 2018-07-02 |
| TW201321404A (en) | 2013-06-01 |
| US20140369964A1 (en) | 2014-12-18 |
| BR112014007766A2 (en) | 2017-04-04 |
| US10358470B2 (en) | 2019-07-23 |
| IN2014CN02982A (en) | 2015-07-03 |
| KR20140095051A (en) | 2014-07-31 |
| PH12014500694B1 (en) | 2020-01-31 |
| CA2850469A1 (en) | 2013-04-04 |
| AU2012317325B2 (en) | 2016-10-06 |
| CN109134642A (en) | 2019-01-04 |
| EP2762489A4 (en) | 2015-05-06 |
| EP2762489A9 (en) | 2015-02-11 |
| EP2762489A1 (en) | 2014-08-06 |
| TWI633115B (en) | 2018-08-21 |
| PH12014500694A1 (en) | 2014-05-12 |
| JPWO2013047846A1 (en) | 2015-03-30 |
| WO2013047846A1 (en) | 2013-04-04 |
| SG11201401071YA (en) | 2014-08-28 |
| KR101979045B1 (en) | 2019-05-15 |
| JP6153470B2 (en) | 2017-06-28 |
| AU2012317325A1 (en) | 2014-04-17 |
| RU2014116550A (en) | 2015-10-27 |
| CN104080803B (en) | 2020-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201601327RA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| IL262667B (en) | An isolated polynucleotide encoding a polypeptide and a pharmaceutical composition comprising the isolated polynucleotide | |
| IL253870B (en) | Certain amino-pyrimidines and pharmaceutical compositions comprising them | |
| ZA201305504B (en) | Compositions containing glycosylated antibodies and uses thereof | |
| EP2699590B8 (en) | Endoglin polypeptides and uses thereof | |
| IL245328B (en) | Pharmaceutical composition comprising carbetocin | |
| IL243264B (en) | Stabilizing agent for pharmaceutical proteins | |
| ZA201400762B (en) | Relaxin fusion polypeptides and uses thereof | |
| IL230918A0 (en) | Modified proteins and peptides | |
| IL230463A0 (en) | Benzamides their preparation and pharmaceutical compositions containing them | |
| SG11201405578TA (en) | Pharmaceutical composition containing peptide | |
| ZA201302113B (en) | Caspofungin composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| SG11201402139UA (en) | High mast2-affinity polypeptides and uses thereof | |
| ZA201207375B (en) | Stabilized pharmaceutical composition | |
| ZA201400340B (en) | Pharmaceutical composition comprising ebastine and fluticasone | |
| SG11201401071YA (en) | Glycosylated polypeptide and pharmaceutical composition containing same | |
| SG10201601324VA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| IL221501A (en) | Pharmaceutical composition comprising myramistin | |
| EP2743252A4 (en) | Tetravalent platinum complex and pharmaceutical composition containing same | |
| PT2918267T (en) | Particulate pharmaceutical composition | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
| GB201121236D0 (en) | Proteins and peptides | |
| GB201121233D0 (en) | Modified proteins and peptides |